SCHEMBL178885

SCHEMBL178885

CCN(CC)c1ccc(/C=C/C=C(\C#N)C(=O)c2c(F)c(F)c(F)c(F)c2F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.51
MEN1 O00255 8/20 0.51
KMT2A Q03164 8/20 0.51
MAPT P10636 8/20 0.51
POLB P06746 3/20 0.51
LMNA P02545 5/20 0.48
MAPK1 P28482 4/20 0.48
L3MBTL1 Q9Y468 4/20 0.48
USP2 O75604 2/20 0.48
RECQL P46063 2/20 0.48
BLM P54132 1/20 0.48
APP P05067 1/20 0.46
TDP1 Q9NUW8 3/20 0.45
NPSR1 Q6W5P4 2/20 0.45
MCL1 Q07820 2/20 0.40
HTT P42858 1/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TLR9 Q9NR96 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14281298 0.83 MEN1 (0.44) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL9361374 0.83 MEN1 (0.58) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL9361378 0.83 MEN1 (0.58) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL11940670 0.81 MEN1 (0.55) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL125106 0.79 ALDH1A1 (0.39) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL5594916 0.79 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL5594913 0.79 ALDH1A1 (0.48) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL5594739 0.79 MAPT (0.53) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL5594742 0.79 MAPT (0.53) ALDH1A1MEN1KMT2AMAPTPOLB
SCHEMBL9360726 0.78 APP (0.56) ALDH1A1MEN1KMT2AMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120059163-A1 Non-linear opticaly active molecules, their synthesis, and use OPTIMER PHOTONICS, INC. (US) 2012-03-08 US disclosed
US-20080004415-A1 Non-linear optically active molecules, their synthesis, and use OPTIMER PHOTONICS, INC. (US) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059163-A1 Non-linear opticaly active molecules, their synthesis, and use INCENP, CYBA, ADCY5 ALDH1A1 371/4885MEN1 4480/4885KMT2A 3041/4885
US-20080004415-A1 Non-linear optically active molecules, their synthesis, and use INCENP, CYBA, PAICS ALDH1A1 378/4885MEN1 4473/4885KMT2A 2961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.